New Pain Solution for Surgeries: A Phase 3 Trial
Imagine having an operation and waking up with less pain and needing fewer strong painkillers. That's what VVZ-149, a new type of pain-blocking drug, aims to do. This small molecule targets two key components in our pain system – the glycine transporter type 2 and the serotonin receptor 5-HT2A. Re